Condensed Consolidated Statements of Changes in Stockholders' Equity - 6 months ended Jun. 30, 2015 - USD ($) $ in Thousands	BioRx, LLC Diplomat Pharmacy, Inc. Shareholders' Equity	BioRx, LLC Common stock	BioRx, LLC	Burman's Apothecary, LLC Diplomat Pharmacy, Inc. Shareholders' Equity	Burman's Apothecary, LLC Common stock	Burman's Apothecary, LLC	Additional Paid-in Capital	Retained Earnings	Diplomat Pharmacy, Inc. Shareholders' Equity	Noncontrolling Interest	Common stock	Total
Balance at the beginning of the period at Dec. 31, 2014							$ 9,893	$ 5,354	$ 164,148	$ 4,579	$ 148,901	$ 168,727
Balance at the beginning of the period (in shares) at Dec. 31, 2014											51,457,023	51,457,023
Changes in shareholders' deficit
Net income								6,249	6,249	(464)		$ 5,785
Issuance of common stock as partial consideration in acquisition	$ 125,697	$ 125,697	$ 125,697	$ 9,578	$ 9,578	$ 9,578
Issuance of common stock as partial consideration in acquisition (in shares)		4,038,853			253,036
Proceeds from public offering, net of issuance costs									187,271		$ 187,271	187,271
Proceeds from public offering, net of issuance costs (in shares)											6,821,125
Repurchase of stock options							(2,104)		(36,298)		$ (34,194)	(36,298)
Excess tax benefits related to share-based awards							4,983		4,983			4,983
Share-based compensation expense							1,232		1,232			1,232
Stock issued upon stock option exercises							(2,147)		5,880		$ 8,027	5,880
Stock issued upon stock option exercises (in shares)											1,043,830
Balance at the end of the period at Jun. 30, 2015							$ 11,857	$ 11,603	$ 468,740	$ 4,115	$ 445,280	$ 472,855
Balance at the end of the period (in shares) at Jun. 30, 2015											63,613,867	63,613,867